Epigenetic changes are increasingly recognized as key contributors to both aging and cancer. These modifications, including DNA methylation, histone modification, and non-coding RNA expression, can alter gene expression without changing the underlying DNA sequence. In aging, epigenetic alterations accumulate, leading to disrupted cellular function and increased cancer susceptibility. Similarly, in cancer, epigenetic changes can activate oncogenes or silence tumor suppressor genes, promoting cancer progression. Targeting epigenetic pathways offers a promising strategy for both preventing age-related diseases and developing novel cancer therapies, as it allows for the reprogramming of cellular behavior at the molecular level.



Title : Multiplexed biosensor detection of cancer biomarkers
Michael Thompson, University of Toronto, Canada
Title : Nanomedicine in over 45,000 patients and no cancer
Thomas Jay Webster, Brown University, United States